370P Low-dose nivolumab with induction chemotherapy for inoperable HNSCC in 111 patients: Response rates, survival, and implications for LMICs

Autor: Georgy, J.T., Thomas, Z., Georgy, R.V., Regi, S., Joel, A., Thumaty, D.B., John, A.O., Devabhaktuni, S., Wisely, J.P., Marimuthu, P.K., Jambunathan, P., Kovilapu, H., Rao, J.P., Tirkey, A., Sasidharan, B.K., Isiah, R., Thomas, M., Chacko, R.T., Singh, A.
Zdroj: In Annals of Oncology November 2023 34 Supplement 4:S1613-S1613
Databáze: ScienceDirect